CNBX PHARMACEUTICALS INC. Convertible Debt, Current
CNBX PHARMACEUTICALS INC. (CNBX) had Convertible Debt, Current of $1.30 million as of 2024-08-31, per its 10-K filed 2024-11-29.
Financial Statements › Balance Sheet › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2024-11-29
- 2024-08-31: Convertible Debt, Current $1.30M.
- 2023-08-31: Convertible Debt, Current $1.34M.
- 2023-05-31: Convertible Debt, Current $1.33M.
- 2023-02-28: Convertible Debt, Current $1.54M.
| Period end | Convertible Debt, Current |
|---|---|
| 2024-08-31 | $1.30M 10-K · filed 2024-11-29 |
| 2023-08-31 | $1.34M 10-K · filed 2024-11-29 |
| 2023-05-31 | $1.33M 10-Q · filed 2023-07-14 |
| 2023-02-28 | $1.54M 10-Q · filed 2023-04-14 |
| 2022-11-30 | $1.76M 10-Q · filed 2023-01-13 |
| 2022-08-31 | $1.76M 10-K · filed 2023-11-30 |
| 2022-05-31 | $1.60M 10-Q · filed 2022-07-14 |
| 2022-02-28 | $1.32M 10-Q · filed 2022-04-12 |
| 2021-11-30 | $1.07M 10-Q · filed 2022-01-13 |
| 2021-08-31 | $871.90K 10-K · filed 2022-11-30 |
| 2021-05-31 | $1.05M 10-Q · filed 2021-07-14 |
| 2021-02-28 | $767.42K 10-Q · filed 2021-04-14 |
| 2020-08-31 | $0.00 10-Q · filed 2021-07-14 |
| 2015-11-30 | $20.00K 10-Q · filed 2016-01-22 |
| 2015-08-31 | $0.00 10-Q · filed 2016-01-22 |